US Markets

White House meeting with top pharmaceutical executives called off

Credit: REUTERS/LEAH MILLIS

A meeting with top pharmaceutical executives that President Donald Trump promised for Tuesday has been called off, a White House official said on Monday.

July 27 (Reuters) - A meeting with top pharmaceutical executives that President Donald Trump promised for Tuesday has been called off, a White House official said on Monday.

"We've been more than accommodating" in trying to set it up, the White House official told Reuters, adding that they couldn't get all the executives at the same time.

Politico earlier reported citing industry sources that the discussion was called off because major drug lobbies, reeling from a series of executive orders, refused to send any members.

Trump on Friday signed four executive orders aimed at lowering the prices Americans pay for prescription drugs, as he faces an uphill re-election battle and criticism over his handling of the coronavirus pandemic.

The drug lobbies PhRMA and BIO were reluctant to send representatives from their member companies after conflicting reports last week about whether the White House would include the rule and little information to date about what the new rule would look like, Politico reported.

Explainer: Trump's plan to cut drug priceshttps://www.reuters.com/article/us-usa-trump-drugprices-explainer/explainer-trumps-plan-to-cut-drug-prices-idUSKCN24S19W

(Reporting by Vishwadha Chander in Bengaluru and Steve Holland in Washington D.C.; Editing by Anil D'Silva)

((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More